Syndrome News and Research

RSS

Review addresses the need for innovative adjuvant approaches and delivery strategies for the advancement of new mucosal vaccines

Researchers reviewed available mucosal vaccines discussing the current challenges and ways to advance the existing approaches.

25 May 2022

Researchers propose DLPE method to extract interpretable and predictive subvisual features from CT scans of COVID-19 inpatients and survivors

Researchers assessed deep learning workflows involved in CT scans of COVID-19.

25 May 2022

The effectiveness of sotrovimab vs. molnupiravir in preventing severe COVID-19 outcomes in non-hospitalized high-risk COVID-19 adult patients

Researchers compared the efficacy of sotrovimab and molnupiravir in preventing severe COVID-19 outcomes among non-hospitalized and high-risk COVID-19 patients across England.

25 May 2022

The effectiveness of molnupiravir and nirmatrelvir/ritonavir in reducing hospitalization and deaths in non-hospitalized COVID-19 patients

Researchers assessed the effectiveness of two orally administered antiviral medications, nirmatrelvir/ritonavir, and molnupiravir, in decreasing hospitalization and deaths among real-world non-hospitalized COVID-19 patients in Hong Kong.

25 May 2022

Study investigates associations between antibody response to COVID-19 vaccination and the risk of subsequent infection

Researchers investigated the associations between antibody levels against SARS-CoV-2 and the risk of subsequent infection.

25 May 2022

Gut microbiota linked to immunocompromised people's variable response to SARS-CoV-2 vaccination

In a recent study posted to the Research Square* preprint server, researchers assessed whether disturbances in the gut microbiota weaken the serological response to the coronavirus disease 2019 (COVID-19) vaccine in inflammatory bowel disease (IBD) patients.

25 May 2022

A study on the safety of BNT162b2 COVID vaccine in children under five

In a recent research paper posted to the medRxiv* preprint server, scientists explored the safety of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) BNT162b2 vaccine in children under five years of age.

25 May 2022

Association between reactogenicity and immunogenicity in SARS-CoV-2 mRNA-1273 vaccination

A recent study currently under review at Scientific Reports journal and posted to the Research Square* preprint server demonstrated a potential positive correlation between reactogenicity and immunogenicity of coronavirus disease 2019 (COVID-19) vaccination.

25 May 2022

The root causes of long-COVID still a mystery

In a recent article posted to the journal Annals of Internal Medicine, researchers presented baseline outcomes from a longitudinal assessment of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC), also known as long-COVID.

25 May 2022

Immunogenicity of BNT162b2 COVID-19 vaccine in melanoma patients receiving immunotherapy

In a recent study under review at the Scientific Reports journal and posted to the Research Square* preprint server, researchers evaluated the efficacy of messenger ribonucleic acid (mRNA)-based coronavirus disease 2019 (COVID-19) vaccine BNT162b2 in cancer patients under treatment with immune checkpoint inhibitors (ICIs).

25 May 2022

Correlation between long-COVID and physical inactivity

In a recent study under review at the Scientific Reports journal and posted to the Research Square* preprint server, researchers assessed whether physical inactivity in coronavirus disease 2019 (COVID-19) survivors led to the development of post-acute sequelae of COVID-19 (PASC), also known as long-COVID.

25 May 2022

Largest study to date on long COVID identifies a broad list of diagnoses

Researchers characterize post-acute sequelae of SARS-CoV-2 infection.

25 May 2022

Anosmia in pediatric COVID-19

The current paper, published in The Pediatric Infectious Disease Journal, examines the prevalence of anosmia in children with COVID-19 using a smell awareness survey.

24 May 2022

Engineered water nanostructures as a new technology against SARS-CoV-2

In a recent study published in the MDPI journal Nanomaterials, a research group from the United States (US) has shown the possibility of inactivating surrogates of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on surfaces with the use of specific water nanostructures incorporated with nature-derived antimicrobials.

24 May 2022

Syndrome News and Research

Review addresses the need for innovative adjuvant approaches and delivery strategies for the advancement of new mucosal vaccines

Researchers propose DLPE method to extract interpretable and predictive subvisual features from CT scans of COVID-19 inpatients and survivors

The effectiveness of sotrovimab vs. molnupiravir in preventing severe COVID-19 outcomes in non-hospitalized high-risk COVID-19 adult patients

The effectiveness of molnupiravir and nirmatrelvir/ritonavir in reducing hospitalization and deaths in non-hospitalized COVID-19 patients

Study investigates associations between antibody response to COVID-19 vaccination and the risk of subsequent infection

Gut microbiota linked to immunocompromised people's variable response to SARS-CoV-2 vaccination

A study on the safety of BNT162b2 COVID vaccine in children under five

Association between reactogenicity and immunogenicity in SARS-CoV-2 mRNA-1273 vaccination

The root causes of long-COVID still a mystery

Immunogenicity of BNT162b2 COVID-19 vaccine in melanoma patients receiving immunotherapy

Correlation between long-COVID and physical inactivity

Largest study to date on long COVID identifies a broad list of diagnoses

Anosmia in pediatric COVID-19

Engineered water nanostructures as a new technology against SARS-CoV-2

Factors affecting exercise during COVID-19 pandemic

Insilico Medicine nominates novel preclinical candidate targeting 3CL protease for COVID-19 treatment

Computational modeling fine tunes RBD-1C aptamer against SARS-CoV-2 S protein

Climate change and the emergence of bat-borne viruses

Study explores the substrate selectivity of the SARS-CoV-2 replicase

The impact of various masking practices on secondary SARS-CoV-2 transmission in a cohort of K–12 schools

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News